Boardroom Alpha
Start trial
10-K primary document
PAVM · Annual Report (Form 10-K) · Filed March 27, 2026

Pavmed Inc — 10-K exhibit

ex_899523.htm
Pavmed Inc on Boardroom Alpha
ex_899523.htm

Exhibit 21.1

 

List of Subsidiaries of the Registrant

(PAVmed Inc. DE - 47-1214177)

 

Subsidiary Legal Entity Name

 

State of Incorporation

Lucid Diagnostics Inc. (82-5488042)

 

Delaware

Subsidiary of PAVmed Inc.

 

(Incorporated May 8, 2018)

 

 

 

LucidDx Labs Inc. (87-41661458)

 

Delaware

- Wholly-Owned Subsidiary of Lucid Diagnostics Inc.

 

(Incorporated November 10, 2021)

 

 

 

Veris Health Inc. (87-0983820)

 

Delaware

- Majority-Owned Subsidiary of PAVmed Inc.

 

(Incorporated April 7, 2021)

 

 

 

Oncodisc Inc (82-4885133)

 

Delaware

Wholly-Owned Subsidiary of Veris Health Inc.

 

(Incorporated February 22, 2018)

 

 

 

PAVmed Subsidiary Corp Inc. (81-1637646)

 

Delaware

Wholly-owned Subsidiary of PAVmed Inc.

 

(Incorporated January 23, 2015)

 

 

 

CapNostics LLC (84-4876240)

 

North Carolina

Wholly-owned Subsidiary of Lucid Diagnostics Inc.

 

(Established January 20, 2020)

 

 

 

PAVmedX Corp (99-3191604)

 

Delaware

Wholly-owned Subsidiary of PAVmed Inc.

 

(Established May 7, 2024)

 

 

 

PortIO Corp (99-3046573)

 

Delaware

Wholly-owned Subsidiary of PAVmedX Corp

 

(Established April 26, 2024)

 

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer